ORS-22
ORS-22 is an immunomodulator with a Kd value of 9.2 nM for human LILRB4. ORS-22 binds directly to the extracellular domain of LILRB4, reverses immunosuppression, restores cytotoxic T cell function, recovers cytokine production, and reduces tumor cell viability. ORS-22 can be used in research related to colorectal cancer and acute myeloid leukemia.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 1311612-43-7
- Fòrmula: C16H18N6OS
- Peso molecular:342.42
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
|
LILRB4 9.2 nM (Kd) |
ORS-22 binds directly to recombinant human LILRB4 extracellular domain with a high affinity, exhibiting a KD of 9.2 nM[1].
ORS-22 (1 μM; 72 h) restores anti-tumor immune activity in SCG2-suppressed PBMC and HCT116 colorectal cancer co-cultures, enhancing cytokine secretion and reducing tumor cell viability[1].
ORS-22 (1 μM; 72 h) restores anti-tumor immune activity in SCG2-suppressed PBMC and THP-1 AML co-cultures, enhancing cytokine secretion, activating cytotoxic T cells, and reducing AML cell viability[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 1311612-43-7
-
Peso molecular 342.42
-
Fòrmula C16H18N6OS
-
SMILES
CN(CC(N1CCN2C(C1)=NN=C2C)=O)C3=NC4=C(S3)C=CC=C4
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)